Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patients

Yaiza Cáceres-Martell, Daniel Fernández-Soto, Carmen Campos-Silva, Eva M. García-Cuesta, Jose M Casasnovas, David Navas-Herrera, Alexandra Beneítez-Martínez, Pedro Martínez-Fleta, Arantzazu Alfranca, Francisco Sánchez-Madrid, Gabriela Escudero López, Carlos Vilches, Ricardo Jara-Acevedo, Hugh T. Reyburn, José M. Rodríguez Frade, Mar Valés-Gómez
doi: https://doi.org/10.1101/2021.04.08.21254348
Yaiza Cáceres-Martell
aDepartment of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel Fernández-Soto
aDepartment of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carmen Campos-Silva
aDepartment of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eva M. García-Cuesta
aDepartment of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose M Casasnovas
bDepartment of Macromolecular structures, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain CNB
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Navas-Herrera
cImmunostep, S.L. Salamanca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alexandra Beneítez-Martínez
cImmunostep, S.L. Salamanca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Pedro Martínez-Fleta
dImmunology Department, Hospital Universitario La Princesa IIS-IP, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Arantzazu Alfranca
dImmunology Department, Hospital Universitario La Princesa IIS-IP, Madrid, Spain
eCIBER Cardiovascular
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Francisco Sánchez-Madrid
dImmunology Department, Hospital Universitario La Princesa IIS-IP, Madrid, Spain
eCIBER Cardiovascular
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriela Escudero López
fInternal Medicine, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlos Vilches
gImmunology Departments, Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana, Majadahonda, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ricardo Jara-Acevedo
cImmunostep, S.L. Salamanca, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hugh T. Reyburn
aDepartment of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
José M. Rodríguez Frade
aDepartment of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mvales@cnb.csic.es jmrfrade@cnb.csic.es
Mar Valés-Gómez
aDepartment of Immunology and Oncology, National Centre for Biotechnology, CNB-CSIC, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: mvales@cnb.csic.es jmrfrade@cnb.csic.es
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Many new aspects of COVID-19 disease, including different clinical manifestations, have been identified during the pandemic. The wide array of symptoms and variation in disease severity after SARS-CoV-2 infection might be related to heterogeneity in the immune responses of different patients. Here we describe a new method for a simple multi-antigen serological test that generates a full picture of seroconversion in a single reaction. The assay is based on the detection by flow cytometry of multiple immunoglobulin classes (isotypes) specific for four SARS-CoV-2 antigens: the Spike glycoprotein (one of the highly immunogenic proteins), its RBD fragment (the major target for neutralising antibodies), the nucleocapsid protein and the main cysteine-like protease. Until now, most diagnostic serological tests measured antibodies to only one antigen and some patients seemed to not make any antibody response. Our data reveal that while most patients respond against all the viral antigens tested, others show a marked bias to make antibodies against either proteins exposed on the viral particle or those released after cellular infection. Combining all the four antigens and using machine learning techniques, it was possible to clearly discriminate between patients and healthy controls with 100% confidence. Further, combination of antigens and different immunoglobulin isotypes in this multi-antigen assay improved the classification of patients with mild and severe disease. Introduction of this method will facilitate massive screenings of patients to evaluate their immune response. It could also support vaccination campaigns both to select non-immune individuals and to distinguish infected patients from vaccine responders.

Competing Interest Statement

JMRF, JMC, HTR and MVG are inventors on the European patent Assay for the detection of the Cys-like protease (Mpro) of SARSCoV-2 [EP20382495.8]. RJ is CEO of Immunostep, S.L. The rest of the authors declare no potential conflict of interest.

Funding Statement

This work was supported by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC-COVID19-028) and grants from Madrid Regional Government IMMUNOTHERCAN [S2017/BMD-3733-2 (MVG)]; the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU): RTI2018-093569-B-I00 (MVG), SAF2017-82940-R (JMRF), SAF2017-83265-R (HTR); SAF2017-82886-R (FSM)]; Health Institute Carlos III (ISCIII) [RETICS Program RD16/0012/0006; RIER (JMRF); PI19/00549 (AA)]. The study was also funded by La Caixa Banking Foundation (HR17-00016 to FSM) and Fondo Supera COVID (CRUE-Banco de Santander) to FSM.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Research project Immune response dynamics as predictor of COVID-19 disease evolution. Implications for therapeutic decision-making approved by La Princesa Health Research Institute Research Ethics Committee (register # 4070) Biobank Hospital Universitario Puerta de Hierro Majadahonda (HUPHM)/Instituto de Investigacion Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA) (PT17/0015/0020 in the Spanish National Biobanks Network) project Development of serological assays for detection of viral antigens (SARS-COV2). The protocol was approved by the Bioethics Committees: CEIm Area de Salud Valladolid Este, Hospital Clinico Universitario de Valladolid, with the number/BIO 2020-98-COVID

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • This work was supported by the Spanish National Research Council (CSIC, project numbers 202020E079 and CSIC-COVID19-028) and grants from Madrid Regional Government “IMMUNOTHERCAN” [S2017/BMD-3733-2 (MVG)]; the Spanish Ministry of Science and Innovation [(MCIU/AEI/FEDER, EU): RTI2018-093569-B-I00 (MVG), SAF2017-82940-R (JMRF), SAF2017-83265-R (HTR); SAF2017-82886-R (FSM)]; Health Institute Carlos III (ISCIII) [RETICS Program RD16/0012/0006; RIER (JMRF); PI19/00549 (AA)]. The study was also funded by “La Caixa Banking Foundation” (HR17-00016 to FSM) and Fondo Supera COVID (CRUE-Banco de Santander) to FSM.

Data Availability

All data are available upon request

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted April 10, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patients
Yaiza Cáceres-Martell, Daniel Fernández-Soto, Carmen Campos-Silva, Eva M. García-Cuesta, Jose M Casasnovas, David Navas-Herrera, Alexandra Beneítez-Martínez, Pedro Martínez-Fleta, Arantzazu Alfranca, Francisco Sánchez-Madrid, Gabriela Escudero López, Carlos Vilches, Ricardo Jara-Acevedo, Hugh T. Reyburn, José M. Rodríguez Frade, Mar Valés-Gómez
medRxiv 2021.04.08.21254348; doi: https://doi.org/10.1101/2021.04.08.21254348
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Bead-assisted SARS-CoV-2 multi-antigen serological test allows effective identification of patients
Yaiza Cáceres-Martell, Daniel Fernández-Soto, Carmen Campos-Silva, Eva M. García-Cuesta, Jose M Casasnovas, David Navas-Herrera, Alexandra Beneítez-Martínez, Pedro Martínez-Fleta, Arantzazu Alfranca, Francisco Sánchez-Madrid, Gabriela Escudero López, Carlos Vilches, Ricardo Jara-Acevedo, Hugh T. Reyburn, José M. Rodríguez Frade, Mar Valés-Gómez
medRxiv 2021.04.08.21254348; doi: https://doi.org/10.1101/2021.04.08.21254348

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (271)
  • Allergy and Immunology (559)
  • Anesthesia (135)
  • Cardiovascular Medicine (1778)
  • Dentistry and Oral Medicine (240)
  • Dermatology (173)
  • Emergency Medicine (317)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (662)
  • Epidemiology (10834)
  • Forensic Medicine (8)
  • Gastroenterology (595)
  • Genetic and Genomic Medicine (2968)
  • Geriatric Medicine (289)
  • Health Economics (534)
  • Health Informatics (1938)
  • Health Policy (837)
  • Health Systems and Quality Improvement (747)
  • Hematology (295)
  • HIV/AIDS (634)
  • Infectious Diseases (except HIV/AIDS) (12535)
  • Intensive Care and Critical Care Medicine (697)
  • Medical Education (300)
  • Medical Ethics (89)
  • Nephrology (325)
  • Neurology (2819)
  • Nursing (152)
  • Nutrition (435)
  • Obstetrics and Gynecology (560)
  • Occupational and Environmental Health (600)
  • Oncology (1475)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (259)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (382)
  • Pediatrics (870)
  • Pharmacology and Therapeutics (368)
  • Primary Care Research (341)
  • Psychiatry and Clinical Psychology (2653)
  • Public and Global Health (5393)
  • Radiology and Imaging (1019)
  • Rehabilitation Medicine and Physical Therapy (599)
  • Respiratory Medicine (729)
  • Rheumatology (330)
  • Sexual and Reproductive Health (294)
  • Sports Medicine (280)
  • Surgery (329)
  • Toxicology (48)
  • Transplantation (151)
  • Urology (127)